Positive AD biomarker results may align with the fact that approximately 20% of patients meeting previous versions of DLB diagnostic criteria [1] had no evidence of DLB, AD being the most common pathology of these cases, while 16% of AD patients with no evidence of synuclein pathology met criteria of probable DLB [133]. This evidence concerns the gene SNCA and Alzheimer disease.